TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
OCS

Oculis Holding AG

Healthcare · Biotechnology

9.10$ -2.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement OCS
Line item 2020 2021 2022 2023 2024 2025
– -3.3% -5.0% -3.2% -22.3% -100.0%
– +2.5% +132.3% +31.6% +78.1% –
– – – – – –
– +2.5% +132.3% +31.6% +78.1% +4.7%
– +16.6% +64.6% +118.4% +48.1% +6.4%
– +7.3% +144.7% +149.3% -73.0% +262.9%
– – – – – –
– +94.8% +25.8% -77.3% -56.3% +24.5%
– – – – – –
– -67.5% +103.7% +94.5% -249.5% –
– – – – – –
– – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?